financetom
Business
financetom
/
Business
/
Meta Aggressive Investments in GenAI, GPUs to Continue, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta Aggressive Investments in GenAI, GPUs to Continue, Morgan Stanley Says
Aug 1, 2024 10:54 AM

01:32 PM EDT, 08/01/2024 (MT Newswires) -- Meta Platforms ( META ) will continue to invest aggressively in generative artificial intelligence and in GPU-enabled platform improvements as return on such investments exceeds expectations, Morgan Stanley said Thursday.

The Facebook and Instagram parent has the "most tangible" return on invested capital among companies that Morgan Stanley covers, the investment firm said after Meta's upbeat Q2 earnings.

"META remains the best case study of how GPU-enabled analyses of leading first party data sets can drive material improvements. In this case it comes thru as better engagement and revenue growth and a growing list of next gen call options," the firm said.

The firm raised its capex estimates for Meta in 2025 and 2026 to $47 billion and $53.1 billion, respectively, from $44.6 billion and $47.5 billion. For 2024, its capex estimate now is $40.0, down from $40.1 billion previously.

Morgan Stanley raised price target for Meta to $575 from $550 and reiterated its overweight rating. Meta shares were up nearly 5% in recent trading.

Price: 497.09, Change: +22.26, Percent Change: +4.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved